Dr. Bitko has over 20 years of experience in virology, biochemistry, and molecular biology, including development of non-adjuvanted and adjuvanted viral vaccines and anti-virals. She joined NanoBio Corporation in July 2011 after having served as a Principal Virologist at Meridian Life Science, where she was involved in development of viral vaccines, recombinant protein biotherapeutic production, and analytical test method development and validation. Dr. Bitko gained extensive experience in molecular virology and innate immune responses to viral infections as a faculty member at the Department of Biochemistry and Molecular Biology at the University of South Alabama, where she studied Respiratory Syncytial Virus, metapneumovirus, and Human Parainfluenza Virus, and developed an advanced RNA interference method for the treatment of RSV infection. Dr. Bitko holds M.S. and Ph.D. degrees in biochemistry.